BIOHAVEN PHARMACTL HLDG CO L's ticker is and the CUSIP is G11196905. A total of 7 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $6,000,000 | – | 70,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 53 | $454,000 | 0.09% |
| BOOTHBAY FUND MANAGEMENT, LLC | 124 | $1,063,000 | 0.04% |
| Hudson Bay Capital Management LP | 70,000 | $6,000,000 | 0.03% |
| GROUP ONE TRADING, L.P. | 63,500 | $5,443,000 | 0.01% |
| JPMORGAN CHASE & CO | 543,100 | $46,549,000 | 0.01% |
| SIMPLEX TRADING, LLC | 202 | $1,731,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |